RELATIVE EXPRESSION OF EFFLUX PUMPS IN MULTI DRUG RESISTANT PSEUDOMONAS AERUGINOSA

Insights

This study investigated antibiotic resistance in Pseudomonas aeruginosa, finding that efflux pumps contribute significantly to resistance against beta-lactam antibiotics. Gene expression analysis revealed varying levels in resistant clinical strains.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Pharmacology

Background:

  • Pseudomonas aeruginosa is a significant opportunistic pathogen known for its high antibiotic resistance.
  • Efflux pumps, such as MexAB-OprM, MexCD-OprJ, and MexXY-OprM, are key intrinsic mechanisms conferring antibiotic resistance in P. aeruginosa.
  • These efflux pumps can lead to cross-resistance against multiple antimicrobial classes, complicating treatment strategies.

Purpose of the Study:

  • To investigate the relative gene expression of efflux pumps in clinical isolates of beta-lactam-resistant Pseudomonas aeruginosa.
  • To correlate phenotypic resistance mechanisms with genotypic efflux pump expression levels.

Main Methods:

  • Identification of 114 clinical P. aeruginosa strains using phenotypic and genotypic methods.
  • Antibiotic susceptibility testing performed according to CLSI guidelines.
  • Phenotypic detection of efflux pump activity using carbonyl cyanide 3-chlorophenylhydrazone (CCCP) as an inhibitor.
  • Quantitative reverse transcription polymerase chain reaction (q-RT PCR) for relative gene expression analysis.

Main Results:

  • The highest rate of resistance was observed against cefotaxime.
  • Variable relative gene expression levels of efflux pumps were detected in all isolates exhibiting positive phenotypic efflux pump activity.
  • A significant proportion of clinical P. aeruginosa strains demonstrated efflux pump-mediated resistance.

Conclusions:

  • Efflux pump activity and associated gene expression are prevalent mechanisms contributing to beta-lactam resistance in clinical P. aeruginosa isolates.
  • Understanding these mechanisms is crucial for developing effective therapeutic strategies against multidrug-resistant P. aeruginosa.
  • Further research into specific efflux pump inhibitors could aid in overcoming resistance.

Related Concept Videos

Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
1.5K
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
37
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.9K
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
99
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
845
ABC Transporters: Exporter01:31

ABC Transporters: Exporter

ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
7.0K